The Risk of Presarcopenia Is Increased Among Female Patients With Primary Sjögren's Syndrome. Issue 1 (January 2022)

• Record Type: Journal Article
• Authors: Colak, Seda; Tekgoz, Emre; Hayme, Serhat; Sonaeren, Ilknur; Cinar, Muhammet; Yilmaz, Sedat
• Is Part Of: Journal of clinical rheumatology. Volume 28:Issue 1(2022)
• Publication Date: 2022-01
• Subjects: disease activity -- inflammation -- primary Sjögren's syndrome -- sarcopenia; Rheumatism -- Periodicals; Rheumatology -- Periodicals; Musculoskeletal system -- Diseases -- Periodicals; Musculoskeletal Diseases -- Periodicals; Rheumatic Diseases -- Periodicals; Rhumatisme -- Périodiques; Rhumatologie -- Périodiques; Appareil locomoteur -- Maladies -- Périodiques; Musculoskeletal system -- Diseases; Rheumatism; Rheumatology; Periodicals; 616.723005
• DOI: 10.1097/RHU.0000000000001669
• Languages: English
• ISSNs: 1076-1608

Abstract

Abstract : Objectives: Sarcopenia is a progressive and generalized loss of muscle mass and function. The aim of this study was to evaluate the frequency of sarcopenia among patients with primary Sjögren's syndrome (SS) and the factors related with sarcopenia. Methods: Forty-four female patients with primary SS and 44 female control subjects were included in this cross-sectional study between February and August 2019. Sarcopenia was evaluated by the handgrip test, Skeletal Muscle Mass Index, and gait speed test. Results: Eleven patients (25.0%) had presarcopenia in the SS group and 2 (4.5%) in the control group ( p = 0.007). Compared with control subjects, SS patients had lower results of hand grip and gait speed tests ( p = 0.005 and p < 0.001, respectively). According to the Mini Nutritional Assessment Short Form, patients with presarcopenia had higher risk of malnutrition compared with patients without sarcopenia ( p = 0.043). Patients with presarcopenia had higher scores in the European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index pain domain and patient visual analog scale for global disease activity compared with patients without sarcopenia ( p = 0.044 and p = 0.036, respectively). In multivariate regression analysis, European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index pain was associated with hand grip strength ( p = 0.016, R 2 = 0.13) and Mini Nutritional Assessment Short Form was associated with Skeletal Muscle Mass Index ( p = 0.005). Conclusions: Risk of sarcopenia is increased in patients with SS. Pain and malnutrition may contribute to presarcopenia. Evaluating pain and patient's global disease activity may help physicians to determine patients with increased risk of sarcopenia. Controlling disease activity and pain and preventing malnutrition may reduce the risk of development of sarcopenia.